Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin.
Karim
A
A
Lawlor
F
F
Black
M M
MM
D005148:Facial Dermatoses / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D017520:Mucinoses / Q000628:therapy; D009230:Myxedema / Q000628:therapy; D012595:Scleroderma, Systemic / Q000628:therapy*
D016756:Immunoglobulins, Intravenous